Beerse, Belgium

Ludo E J Kennis


Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
6 patents (USPTO):

Title: The Innovative Contributions of Ludo E J Kennis

Introduction

Ludo E J Kennis, a notable inventor based in Beerse, Belgium, has made significant contributions to the field of medicinal chemistry. With a total of six patents to his name, Kennis is known for his innovative approaches to treating various neurological and psychological conditions.

Latest Patents

Among his recent works, Kennis has developed pyrrolopyridine derivatives substituted with cyclic amino groups. These compounds serve as antagonists against CRF (Corticotropin-Releasing Factor) receptors, targeting therapeutic applications for diseases like depression, anxiety, and Alzheimer's disease. Another notable patent includes pyrrolopyrimidine and pyrrolotriazine derivatives, which also aim to tackle a range of disorders, including Huntington's chorea, eating disorders, and epilepsy. The high affinity of these compounds for CRF receptors positions them as potential solutions for illnesses where CRF is involved.

Career Highlights

Kennis currently works with Taisho Pharmaceutical Co., Ltd., where his research continues to influence the development of new therapeutic agents. His dedication to innovation in this vital area of healthcare highlights his commitment to improving patient outcomes.

Collaborations

Throughout his career, Kennis has collaborated with esteemed colleagues such as Atsuro Nakazato and Taketoshi Okubo. These partnerships have enhanced the scope of his work, combining expertise to further advance research in pharmaceutical sciences.

Conclusion

Ludo E J Kennis exemplifies the spirit of innovation within the pharmaceutical industry. His contributions through patenting novel compounds showcase his dedication to addressing critical health issues and advancing therapeutic options for various disorders. As he continues to collaborate with other professionals, the potential for impactful discoveries remains high.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…